Publications:

POLE/POLD1 mutation in non-exonuclease domain matters for predicting efficacy of immune-checkpoint-inhibitor therapy.

Clinical And Translational Medicine

Chen, Yan-Xing YX; Wang, Zi-Xian ZX; Yuan, Shu-Qiang SQ; Jiang, Teng-Jia TJ; Huang, You-Sheng YS; Xu, Rui-Hua RH; Wang, Feng F; Zhao, Qi Q

Publication Date: 2021-09

Variant appearance in text: POLE: Y1398*

PubMed Link: 34586735

Variant Present in the following documents:

• CTM2-11-e524-s001.xlsx, sheet 2

View BVdb publication page

Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer.

The Oncologist

Guo, Yun Y; Guo, Xian-Ling XL; Wang, Shuang S; Chen, Xinyu X; Shi, Jiaochun J; Wang, Jian J; Wang, Kai K; Klempner, Samuel J SJ; Wang, Weifeng W; Xiao, Min M

Publication Date: 2020-11

Variant appearance in text: POLE: Y1398*

PubMed Link: 32627883

Variant Present in the following documents:

• Main text
• ONCO-25-e1671.pdf

View BVdb publication page